Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFerrexpo Regulatory News (FXPO)

  • This share is currently suspended. It was suspended at a price of 28.58

Share Price Information for Ferrexpo (FXPO)

Share Price is delayed by 15 minutes
Get Live Data
28.58    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £168.16m
FXPO Live PriceLast checked at - London Stock Exchange

Intraday Ferrexpo Share Chart

Independent Review

4 Feb 2019 07:00

RNS Number : 9506O
Ferrexpo PLC
04 February 2019
 

 

4 February 2019

 

Ferrexpo plc("Ferrexpo", the "Group" or the "Company")

 

Independent Review

 

Ferrexpo's auditors, Deloitte LLP, has received copies of bank statements directly from a charitable foundation called Blooming Land, as part of its process to verify Blooming Land's use of contributions made by Ferrexpo. Blooming Land is a Ukrainian charity which was established with the primary function of co-ordinating the Group's CSR programme and provides medical and social services to local, regional and national communities throughout Ukraine. As noted in the 1H 2018 results, Blooming Land and its sub-funds are separately managed.

 

The copy bank statements from Blooming Land contained as yet unexplained discrepancies. This has caused the Board of Ferrexpo to decide to conduct a comprehensive independent review and is in the process of scoping the work.

 

As reported in the 1H 2018 results, Ferrexpo donated US$9.5 million to Blooming Land in 1H 2018. Ferrexpo has not made any further donations to Blooming Land since May 2018.

 

The Group intends to announce its FY 2018 results as planned on 20 March 2019. At the current time, the Board cannot guarantee that the review will be complete by then, or complete favourably. Deloitte has indicated that it may qualify or otherwise modify its audit opinion relating to the FY 2018 accounts if this is the case.

 

Following the Group's 4Q 2018 trading update, as announced on 8 January 2019, Ferrexpo expects full year 2018 EBITDA to be approximately US$500 million (subject to audit).

 

This announcement contains inside information in relation to the Company. The person responsible for making this notification is Brian McLelland, Interim Company Secretary.

 

 

For further information contact:

Ferrexpo:

Ingrid McMahon

Head of Investor Relations

 

+44 207 389 8304

 

Maitland:

James Isola

+44 207 379 5151

Partner

 

Notes to Editors:

Ferrexpo is a Swiss headquartered iron ore company with assets in Ukraine. It has been mining, processing and selling high quality iron ore pellets to the global steel industry for 40 years. Ferrexpo's resource base is one of the largest iron ore deposits in the world. In 2018, the Group produced 10.6 million tonnes of pellets ranking it as the 3rd largest exporter of pellets to the global steel industry with a market share of approximately 8.5%. Ferrexpo has a diversified customer base supplying steel mills in Austria, Germany, Japan, South Korea, Taiwan, China, Slovakia, the Czech Republic, Turkey and Vietnam. Ferrexpo has a premium listing on the main market of the London Stock Exchange under the ticker FXPO. For further information, please visit www.ferrexpo.com

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCTIMFTMBAMMML
Date   Source Headline
29th May 20267:00 amRNSNotice of 2026 Annual General Meeting
28th Apr 20267:00 amRNSFunding Update and Delay in Financial Statements
22nd Apr 20267:00 amRNSUpdate on funding options
20th Apr 20267:00 amRNSSale of Iron Destiny and Update on Funding Options
15th Apr 20267:00 amRNSProduction Report for 1Q 2026
1st Apr 20269:41 amRNSTrading Update
9th Mar 20267:00 amRNSOperations and Corporate Update
2nd Mar 20268:20 amRNSDirector/PDMR Shareholding
24th Feb 20263:35 pmRNSUpdate regarding Ukrainian subsidiary
20th Jan 20263:39 pmRNSUpdate on operations in Ukraine
14th Jan 20267:00 amRNSProduction Report for 4Q 2025
31st Dec 20257:00 amRNS-REnd of year letter from Interim Executive Chair
31st Dec 20257:00 amRNS-REnd of year letter from Interim Executive Chair
14th Nov 20257:05 amRNSDirector Declaration
10th Nov 20257:00 amRNSLimited attack on power infrastructure
4th Nov 20257:00 amRNSPublication of Responsible Business Report
6th Oct 20257:00 amRNSProduction Report for 3Q 2025
11th Sep 202511:59 amRNSGeneral Meeting voting results
11th Aug 20257:00 amRNSPublication of Notice of General Meeting 2025
6th Aug 20257:00 amRNSInterim Results for six months ended 30 June 2025
7th Jul 20257:00 amRNSProduction Report for 2Q 2025
10th Jun 20254:48 pmRNSDirector/PDMR Shareholding
9th Jun 20254:35 pmRNSDirector/PDMR Shareholding
22nd May 202512:47 pmRNSResult of AGM
16th May 20255:00 pmRNSReport on Payments to Governments
15th May 202512:15 pmRNSUpdate regarding Ukrainian subsidiary
30th Apr 20257:00 amRNSLetter to shareholders re: auditor engagement
17th Apr 20255:32 pmRNSUkraine subsidiaries VAT refunds
10th Apr 20257:00 amRNSNotice of Annual General Meeting and 2024 ARA
7th Apr 20257:00 amRNSProduction Report for 1Q 2025
21st Mar 20257:00 amRNSStatement regarding Ukraine VAT refunds
19th Mar 20258:00 amRNSInternational Investment Agreements Notification
19th Mar 20257:00 amRNSFull Year Financial Results for 2024
11th Mar 20257:00 amRNSAnnouncement of Full Year 2024 Financial Results
5th Mar 20257:00 amRNSResponse to SBI Statement
4th Feb 20253:17 pmRNSUpdate regarding Ukrainian subsidiary
23rd Jan 20259:52 amRNSUpdate regarding Ukrainian Subsidiary
16th Jan 202511:30 amRNSUpdate regarding Ukrainian subsidiary
13th Jan 20257:00 amRNSResignation of Non-Executive Director
9th Jan 20257:00 amRNSProduction Report for 4Q 2024
30th Dec 20245:00 pmRNSPublication of Responsible Business Report
30th Dec 20245:00 pmRNSPublication of Climate Change Report
7th Oct 20247:00 amRNSProduction Report for 3Q 2024
19th Sep 202412:31 pmRNSGeneral Meeting voting results
12th Aug 20247:00 amRNSNotice of General Meeting 2024
5th Aug 20244:50 pmRNSUpdate on restrictions on shares in subsidiary
31st Jul 202412:28 pmRNSInterim Results for six months ended 30 June 2024
31st Jul 20247:00 amRNSInterim Results for six months ended 30 June 2024
30th Jul 20245:50 pmRNSInterim Results Advisory
8th Jul 20247:00 amRNSProduction Report for 2Q 2024 and 1H 2024

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.